Comparison of Erector Spinae Plane Block vs Intravenous Lidocaine for Chronic Pain Post Mastectomy.
CompletedNot applicableNCT06383845
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients undergoing breast surgery were divided into two groups: Intravenous Lidocaine (Lido-IV) vs Erector Spinae Block (ESP). For Lido-IV group, patients received a loading dose of Lidocaine than a continuous infusion till the end of surgery. For ESP group, an ultrasound guided ESP Block was perormed before anesthetic induction. Persistant pain post mastectomy was assessed by SFM-PQ score at 1, 3 and 6 months post surgery.
Study details
- Official title
- Comparison of Erector Spinae Plane Block and Intravenous Lidocaine for Chronic Pain Post Mastectomy: a Randomized Controlled Trial
- Conditions
- Breast Surgery
- Interventions
- Drug: Lido-IV
- Drug: ESP Block
- Sponsor
- University Tunis El Manar
- Start date
- 2023-01-01
- Primary completion
- 2024-01-31
- Sex
- Female
- Age range
- from 18 Years to 90 Years
- Results posted
- No results posted in this snapshot
- Countries
- Tunisia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patients * patients aged 18 and older * American Society of anesthesiologists classification I or II * patients proposed for planned mastectomy with axillary lymph node dissection. * hemodynamic stability. Exclusion Criteria: * patient refusal * male gender * history of major surgery within the year. * allergy to local anesthetics * BMI\>40 * hemodynamic instability * Patients on long-term analgesics * Severe heart and/or kidney damage * neurological/psychiatric impairment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06383845